Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: bentway who wrote (489876)	6/22/2009 3:22:38 PM
From: Tenchusatsu	Respond to of 1572033

Bentway, > The brand name, on-patent prescription meds are made in the same FDA-inspected Indian factories as the generics. You took away the wrong point. It's not just the fact that they're made in India. The brand name non-generic medications get the most FDA scrutiny for obvious reasons. Less obvious is the inconsistent regulation for generics, which come from a variety of sources (such as India) and are often not ensured to be exactly the same as the brand names they are meant to replace. I don't have a link, but this is an issue that several pharmacists are already aware of. That's just one of many examples of how the current problems in health care will be multiplied once we move to universal. Tenchusatsu